Description

Product Description

Pasireotide Acetate is a synthetic cyclic peptide and a second-generation somatostatin analog intended strictly for research and laboratory use only. Compared with first-generation somatostatin analogs, Pasireotide Acetate demonstrates a broader somatostatin receptor (SSTR) binding spectrum, showing particularly high affinity for SSTR5, while retaining functional activity at SSTR1, SSTR2, and SSTR3.

In experimental research, Pasireotide Acetate is commonly applied as a reference compound in endocrine system studies, pituitary and neuroendocrine tumor (NET) models, and somatostatin receptor pharmacology investigations. Its well-characterized molecular structure and consistent activity profile make it suitable for controlled in vitro and in vivo studies focused on hormone secretion regulation and GPCR-mediated signaling pathways.

Product Specifications

Key Features

• Broad somatostatin receptor subtype binding profile

• High affinity toward SSTR5 for endocrine research applications

• High purity suitable for reproducible experimental outcomes

• Stable lyophilized formulation for laboratory storage

• Applicable to in vitro and in vivo research models

Applications

Pasireotide Acetate is widely used in the following research areas:

• Endocrine signaling and hormone regulation studies

• Neuroendocrine tumor (NET) research models

• Pituitary adenoma and ACTH / GH secretion investigations

• Somatostatin receptor subtype comparison studies

• GPCR signaling, receptor internalization, and desensitization research

For detailed mechanistic analysis and experimental design discussion, see the corresponding Pasireotide Acetate 03 template research article.

Usage & Reconstitution Guidelines

Pasireotide Acetate should be handled using standard sterile laboratory techniques. The lyophilized powder is typically reconstituted with sterile water or dilute acidic buffer to prepare stock solutions for experimental use.

Aliquoting after reconstitution is recommended to minimize repeated freeze–thaw cycles. Experimental concentrations should be optimized according to receptor expression levels and specific study objectives.

Storage & Stability

• Store unopened vials at −20 °C

• Protect from moisture and light

• Avoid repeated freeze–thaw cycles

• Properly stored aliquots remain stable for extended research periods

Shipping Guarantee

All Pasireotide Acetate shipments are prepared in accordance with standardized laboratory material handling and packaging procedures.

• Light- and moisture-protected packaging

• Secure outer containers to prevent damage

• Batch-level labeling for traceability

• Handling protocols designed to preserve peptide stability

Trade Assurance

Each batch of Pasireotide Acetate undergoes internal quality verification prior to release.

• Identity and purity confirmation

• Specification conformity checks

• Batch consistency review

• Lot-level traceability documentation

Payment Support

To support laboratories, research institutions, and commercial research partners, multiple payment options are available:

• Wire Transfer (T/T)

• Business-to-business payment methods

• Region-specific payment solutions upon request

Documentation Available

The following documentation may be provided upon request:

• Certificate of Analysis (COA)

• HPLC purity report

• Mass spectrometry data

• Batch and lot information

Disclaimer

This product is intended for research and laboratory use only.
Not for human or veterinary use.
All handling and experimental applications must comply with applicable laws, institutional policies, and laboratory safety regulations.